Medistep Healthcare Ltd
₹ 25.0
-0.20%
05 Dec
- close price
About
Incorporated in June 2023, Medistep Healthcare Limited is a pharmaceutical company producing sanitary pads, energy powder, and various pharmaceutical, nutraceutical, intimate, and surgical products.[1]
Key Points
- Market Cap ₹ 35.5 Cr.
- Current Price ₹ 25.0
- High / Low ₹ 53.0 / 22.3
- Stock P/E 6.54
- Book Value ₹ 24.5
- Dividend Yield 0.00 %
- ROCE 37.8 %
- ROE 29.0 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 1.02 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2024 9m | Mar 2025 | TTM | |
|---|---|---|---|
| 31.60 | 49.65 | 63.47 | |
| 27.64 | 44.04 | 56.18 | |
| Operating Profit | 3.96 | 5.61 | 7.29 |
| OPM % | 12.53% | 11.30% | 11.49% |
| 0.01 | 0.00 | 0.00 | |
| Interest | 0.06 | 0.04 | 0.01 |
| Depreciation | 0.02 | 0.03 | 0.03 |
| Profit before tax | 3.89 | 5.54 | 7.25 |
| Tax % | 25.19% | 25.09% | |
| 2.91 | 4.14 | 5.43 | |
| EPS in Rs | 5.94 | 3.96 | 4.44 |
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 57% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 29% |
Balance Sheet
Figures in Rs. Crores
| Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|
| Equity Capital | 4.90 | 10.47 | 14.21 |
| Reserves | 6.79 | 6.37 | 20.60 |
| 0.33 | 0.64 | 0.59 | |
| 2.93 | 5.51 | 7.29 | |
| Total Liabilities | 14.95 | 22.99 | 42.69 |
| 0.15 | 0.12 | 0.13 | |
| CWIP | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 |
| 14.80 | 22.87 | 42.56 | |
| Total Assets | 14.95 | 22.99 | 42.69 |
Cash Flows
Figures in Rs. Crores
| Mar 2024 | Mar 2025 | |
|---|---|---|
| -7.11 | 0.02 | |
| -0.15 | 0.00 | |
| 7.24 | 1.28 | |
| Net Cash Flow | -0.02 | 1.30 |
Ratios
Figures in Rs. Crores
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Debtor Days | 158.82 | 147.84 |
| Inventory Days | 12.41 | 9.23 |
| Days Payable | 18.81 | 20.55 |
| Cash Conversion Cycle | 152.42 | 136.52 |
| Working Capital Days | 133.76 | 113.29 |
| ROCE % | 37.83% |
Documents
Announcements
-
Outcome of Board Meeting
11 November 2025 - Board approved H1 (ended 30 Sep 2025) results: revenue Rs3,506.88L, PAT Rs297.09L; IPO proceeds largely utilised.
-
Outcome of Board Meeting
11 November 2025 - Approved H1 FY2026 unaudited results: revenue Rs3,506.88L, PAT Rs297.09L, EPS Rs2.61; IPO proceeds utilisation disclosed.
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
28 October 2025 - Corporate governance report not applicable for quarter/half-year ended 30 Sep 2025 due to SME listing.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
10 October 2025 - RTA certificate under Regulation 74(5) for quarter and half-year ended September 30, 2025.
-
Shareholders meeting
1 October 2025 - AGM results: four resolutions passed — FY2024-25 financials, auditors appointed, MD re-appointed (15 Feb 2026–14 Feb 2031).
Business Profile[1]
The company manufactures sanitary pads under the brand name Drystep and produces nutraceutical products, including Vitastep-Z energy powder. Additionally, it is active in the trading and distribution of pharmaceutical products, surgical equipment, nutraceuticals, and intimate care and hygiene products, offering a diverse range of healthcare solutions.